Abstract

TCM Zheng Classification and Clinical Trials 2014.

Highlights

  • Two cohort studies were gathered, “Chinese Herbal Decoction Based on Syndrome Differentiation as Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer: An Exploratory and Small Prospective Cohort Study”; 357 herbal decoctions were prescribed for 29 patients based on Zheng classification to observe the treatment effect and treatment length of herbal decoctions

  • We are on the way from traditional Chinese medicine (TCM) Zheng classification in clinical trial to development of clinical practice guideline

  • Many clinical trials have been conducted in China to evaluate the effectiveness of TCM, but many of the studies are with poor quality and may be inaccessible to non-Chinese scientists

Read more

Summary

Introduction

Two cohort studies were gathered, “Chinese Herbal Decoction Based on Syndrome Differentiation as Maintenance Therapy in Patients with Extensive-Stage Small-Cell Lung Cancer: An Exploratory and Small Prospective Cohort Study”; 357 herbal decoctions were prescribed for 29 patients based on Zheng classification to observe the treatment effect and treatment length of herbal decoctions. Editorial TCM Zheng Classification and Clinical Trials 2014 In continuation of the last year’s special issue “TCM Zheng Classification and Clinical Trials,” the time for 2014 issue has come.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call